Paul T. Wingfield

Paul T. Wingfield's AcademicInfluence.com Rankings

Paul T. Wingfield

Computer Science

#7961

World Rank

#8377

Historical Rank

Machine Learning

#3126

World Rank

#3165

Historical Rank

Artificial Intelligence

#3425

World Rank

#3475

Historical Rank

Database

#5014

World Rank

#5208

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Paul T. Wingfield's Degrees

PhD Computer Science University of California, Berkeley
Masters Computer Science Stanford University

Similar Degrees You Can Earn

Why Is Paul T. Wingfield Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Paul T. Wingfield's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Activated STING in a vascular and pulmonary syndrome. (2014) (903)
Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation (1993) (855)
Overcoming the overlap problem in the assignment of 1H NMR spectra of larger proteins by use of three-dimensional heteronuclear 1H-15N Hartmann-Hahn-multiple quantum coherence and nuclear Overhauser-multiple quantum coherence spectroscopy: application to interleukin 1 beta. (1989) (805)
A novel, highly stable fold of the immunoglobulin binding domain of streptococcal protein G. (1993) (729)
Interleukin-35 Induces Regulatory B Cells that Suppress CNS Autoimmune Disease (2014) (571)
TIMP-2 Mediated Inhibition of Angiogenesis An MMP-Independent Mechanism (2003) (504)
Three‐dimensional solution structure of the 44 kDa ectodomain of SIV gp41 (1998) (388)
Analysis of the backbone dynamics of interleukin-1.beta. using two-dimensional inverse detected heteronuclear nitrogen-15-proton NMR spectroscopy (1990) (381)
The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef. Mapping of the Nef binding surface by NMR. (1996) (361)
Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding. (1993) (342)
The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase (1996) (338)
Solution NMR of proteins within polyacrylamide gels: Diffusional properties and residual alignment by mechanical stress or embedding of oriented purple membranes (2000) (303)
Cloning and expression of a cDNA for human thioredoxin. (1988) (233)
Specific complex of human immunodeficiency virus type 1 rev and nucleolar B23 proteins: dissociation by the Rev response element (1991) (216)
Flexibility and function in HIV-1 protease (1995) (210)
Protein precipitation using ammonium sulfate. (2001) (193)
High-resolution mass spectrometry of viral assemblies: Molecular composition and stability of dimorphic hepatitis B virus capsids (2008) (192)
Micelle-induced curvature in a water-insoluble HIV-1 Env peptide revealed by NMR dipolar coupling measurement in stretched polyacrylamide gel. (2002) (188)
Assignment of the side-chain proton and carbon-13 resonances of interleukin-1.beta. using double- and triple-resonance heteronuclear three-dimensional NMR spectroscopy (1990) (174)
IL-1 enhances expansion, effector function, tissue localization, and memory response of antigen-specific CD8 T cells (2013) (173)
Refined solution structure and backbone dynamics of HIV‐1 Nef (1997) (162)
Complete resonance assignment for the polypeptide backbone of interleukin 1 beta using three-dimensional heteronuclear NMR spectroscopy. (1990) (160)
A powerful method of sequential proton resonance assignment in proteins using relayed 15N‐1H multiple quantum coherence spectroscopy (1989) (156)
Anisotropic rotational diffusion of perdeuterated HIV protease from 15N NMR relaxation measurements at two magnetic fields (1996) (154)
High-resolution three-dimensional structure of interleukin 1 beta in solution by three- and four-dimensional nuclear magnetic resonance spectroscopy. (1992) (150)
Kinetics of folding of the all-beta sheet protein interleukin-1 beta. (1993) (144)
Analysis of the backbone dynamics of interleukin-1 beta using two-dimensional inverse detected heteronuclear 15N-1H NMR spectroscopy. (1990) (142)
Solution NMR evidence that the HIV-1 protease catalytic aspartyl groups have different ionization states in the complex formed with the asymmetric drug KNI-272. (1996) (133)
Overview of the Purification of Recombinant Proteins (2015) (133)
Implications of the HIV-1 Rev dimer structure at 3.2 Å resolution for multimeric binding to the Rev response element (2010) (132)
High-resolution three-dimensional structure of reduced recombinant human thioredoxin in solution. (1992) (131)
Three-dimensional structure of ubiquinol:cytochrome c reductase from Neurospora mitochondria determined by electron microscopy of membrane crystals. (1981) (131)
Heparin Binding and Oligomerization of Hepatocyte Growth Factor/Scatter Factor Isoforms (1997) (128)
Identification and localization of bound internal water in the solution structure of interleukin 1.beta. by heteronuclear three-dimensional proton rotating-fram Overhauser nitrogen-15-proton multiple quantum coherence NMR spectroscopy (1990) (127)
IL-12p35 induces expansion of IL-10 and IL-35-expressing regulatory B cells and ameliorates autoimmune disease (2017) (126)
Tumour necrosis factor is a compact trimer (1987) (122)
Structure and dynamics of micelle-associated human immunodeficiency virus gp41 fusion domain. (2005) (117)
Comparative immunogenicity of hepatitis B virus core and E antigens. (1988) (116)
NMR and X-ray Evidence That the HIV Protease Catalytic Aspartyl Groups Are Protonated in the Complex Formed by the Protease and a Non-Peptide Cyclic Urea-Based Inhibitor (1994) (115)
The crystal structure of the SIV gp41 ectodomain at 1.47 A resolution. (1999) (113)
Stability and shape of hepatitis B virus capsids in vacuo. (2008) (110)
Preparation and Extraction of Insoluble (Inclusion‐Body) Proteins from Escherichia coli (1995) (110)
An Unusual Topological Structure of the HIV-1 Rev Response Element (2013) (108)
Nucleolar protein B23 stimulates nuclear import of the HIV-1 Rev protein and NLS-conjugated albumin. (1997) (107)
Biophysical and Functional Characterization of Full-length, Recombinant Human Tissue Inhibitor of Metalloproteinases-2 (TIMP-2) Produced in Escherichia coli (1999) (107)
Purification and characterization of human interleukin‐1β expressed in recombinant Escherichia coli (1986) (104)
Phage display of intact domains at high copy number: A system based on SOC, the small outer capsid protein of bacteriophage T4 (1996) (101)
Production of Recombinant Proteins (2002) (98)
BACH2 immunodeficiency illustrates an association between super-enhancers and haploinsufficiency (2017) (96)
Regulation of HIV-1 protease activity through cysteine modification. (1996) (95)
Using Amide 1H and 15N Transverse Relaxation To Detect Millisecond Time-Scale Motions in Perdeuterated Proteins: Application to HIV-1 Protease (1998) (92)
Dissociation of Heparan Sulfate and Receptor Binding Domains of Hepatocyte Growth Factor Reveals That Heparan Sulfate-c-Met Interaction Facilitates Signaling* (2001) (92)
N-terminal methionine-specific peptidase in Salmonella typhimurium. (1987) (91)
Four-Dimensional 15N-Separated NOESY of Slowly Tumbling Perdeuterated 15N-Enriched Proteins. Application to HIV-1 Nef (1995) (90)
Measurement of 3hJNC′ connectivities across hydrogen bonds in a 30 kDa protein (1999) (89)
The morphogenic linker peptide of HBV capsid protein forms a mobile array on the interior surface (2002) (84)
Structure, assembly, and antigenicity of hepatitis B virus capsid proteins. (2005) (81)
Solution Structure of Anti-HIV-1 and Anti-Tumor Protein MAP30 Structural Insights into Its Multiple Functions (1999) (76)
Preparation and Extraction of Insoluble (Inclusion‐Body) Proteins from Escherichia coli (2012) (73)
Activator Gcn4 Employs Multiple Segments of Med15/Gal11, Including the KIX Domain, to Recruit Mediator to Target Genes in Vivo*♦ (2009) (70)
Biophysical and enzymatic properties of the catalytic domain of HIV-1 integrase. (1994) (68)
The UL36 Tegument Protein of Herpes Simplex Virus 1 Has a Composite Binding Site at the Capsid Vertices (2012) (67)
N‐Terminal Methionine Processing (2017) (67)
Three‐dimensional solution structure of the HIV‐1 protease complexed with DMP323, a novel cyclic urea‐type inhibitor, determined by nuclear magnetic resonance spectroscopy (1996) (65)
HIV-2 protease is inactivated after oxidation at the dimer interface and activity can be partly restored with methionine sulphoxide reductase. (2000) (64)
Studies on the solution conformation of human thioredoxin using heteronuclear 15N-1H nuclear magnetic resonance spectroscopy. (1990) (62)
Analysis of the backbone dynamics of the ribonuclease H domain of the human immunodeficiency virus reverse transcriptase using 15N relaxation measurements. (1992) (61)
Membrane crystals of ubiquinone:cytochrome c reductase from Neurospora mitochondria (1979) (61)
SIMULTANEOUS MEASUREMENT OF 1H-15N, 1H-13C', AND 15N-13C' DIPOLAR COUPLINGS IN A PERDEUTERATED 30 KDA PROTEIN DISSOLVED IN A DILUTE LIQUID CRYSTALLINE PHASE (1998) (59)
The solution structure of the N-terminal domain of hepatocyte growth factor reveals a potential heparin-binding site. (1998) (58)
Antigenic switching of hepatitis B virus by alternative dimerization of the capsid protein. (2013) (58)
Determination of the secondary structure and molecular topology of interleukin-1 beta by use of two- and three-dimensional heteronuclear 15N-1H NMR spectroscopy. (1990) (58)
Internal dynamics of the homotrimeric HIV-1 viral coat protein gp41 on multiple time scales. (2013) (58)
Peptides Corresponding to the Heptad Repeat Motifs in the Transmembrane Protein (gp41) of Human Immunodeficiency Virus Type 1 Elicit Antibodies to Receptor-Activated Conformations of the Envelope Glycoprotein (2001) (58)
Proteolytic Processing of HIV-1 Protease Precursor, Kinetics and Mechanism* (1999) (58)
Rabbit IL-1. Cloning, expression, biologic properties, and transcription during endotoxemia. (1989) (57)
Identification and dynamics of a heparin-binding site in hepatocyte growth factor. (1999) (56)
Subunit exchange rates in Hepatitis B virus capsids are geometry- and temperature-dependent. (2010) (54)
The G18V CRYGS mutation associated with human cataracts increases gammaS-crystallin sensitivity to thermal and chemical stress. (2009) (54)
An easy way to include weak alignment constraints into NMR structure calculations (2001) (54)
Functional and biophysical characterization of recombinant human hepatocyte growth factor isoforms produced in Escherichia coli. (1997) (53)
Human Immunodeficiency Virus Rev Protein Recognizes a Target Sequence in Rev-Responsive Element RNA within the Context of RNA Secondary Structure (1992) (53)
NMR Evidence for the Displacement of a Conserved Interior Water Molecule in HIV Protease by a Non-Peptide Cyclic Urea-Based Inhibitor (1994) (52)
Biochemical and biological comparison of HIV-1 NEF and ras gene products. (1991) (51)
The conformation and stability of recombinant-derived granulocyte-macrophage colony stimulating factors. (1988) (50)
C-terminal peptide identification by fast atom bombardment mass spectrometry. (1988) (49)
The extracellular domain of immunodeficiency virus gp41 protein: Expression in Escherichia coli, purification, and crystallization (1997) (49)
Association properties of betaB2- and betaA3-crystallin: ability to form dimers. (1997) (49)
Reversible Oxidative Modification as a Mechanism for Regulating Retroviral Protease Dimerization and Activation (2003) (48)
HIV-1 Rev Depolymerizes Microtubules to Form Stable Bilayered Rings (2000) (48)
Point mutations of human interleukin‐1 with decreased receptor binding affinity (1986) (47)
Protein Precipitation Using Ammonium Sulfate (2016) (47)
β-Crystallin association (2004) (46)
Conformation, stability, and folding of interleukin 1 beta. (1987) (45)
Enzymology of ubiquinone-utilizing electron transfer complexes in nonionic detergent. (1979) (43)
Bound Water Molecules at the Interface between the HIV-1 Protease and a Potent Inhibitor, KNI-272, Determined by NMR (1996) (43)
Determination of solvent content in cavities in IL-1β using experimentally phased electron density (2006) (42)
Z-disc-associated, Alternatively Spliced, PDZ Motif-containing Protein (ZASP) Mutations in the Actin-binding Domain Cause Disruption of Skeletal Muscle Actin Filaments in Myofibrillar Myopathy* (2014) (42)
Flexibility and Function in HIV Protease: Dynamics of the HIV-1 Protease Bound to the Asymmetric Inhibitor Kynostatin 272 (KNI-272) (1998) (41)
Monomer‐trimer equilibrium of the ectodomain of SIV gp41: Insight into the mechanism of peptide inhibition of HIV infection (1999) (41)
Construction of an enzymatically active ribonuclease H domain of human immunodeficiency virus type 1 reverse transcriptase. (1994) (41)
Determination of the positions of bound water molecules in the solution structure of reduced human thioredoxin by heteronuclear three-dimensional nuclear magnetic resonance spectroscopy. (1991) (41)
Long‐range 15N‐1H correlation as an aid to sequential proton resonance assignment of proteins Application to the DNA‐binding protein ner from phage Mu (1988) (41)
Purification and characterization of the RNase H domain of HIV‐1 reverse transcriptase expressed in recombinant Escherichia coli (1990) (40)
Assignment of the side-chain 1H and 13C resonances of interleukin-1 beta using double- and triple-resonance heteronuclear three-dimensional NMR spectroscopy. (1990) (39)
Tumor necrosis factor inhibitor: purification, NH2−terminal amino acidsequence and evidence for anti‐inflammatory and immunomodulatory activities (1990) (38)
Preparation and characterization of human interleukin-5 expressed in recombinant Escherichia coli. (1990) (37)
Determination of the secondary structure and global topology of the 44 kDa ectodomain of gp41 of the simian immunodeficiency virus by multidimensional nuclear magnetic resonance spectroscopy. (1997) (36)
Oculocutaneous albinism type 1: link between mutations, tyrosinase conformational stability, and enzymatic activity (2017) (36)
Recombinant-derived interleukin-1α stabilized against specific deamidation (1987) (36)
Mapping hydration water molecules in the HIV-1 protease/DMP323 complex in solution by NMR spectroscopy. (1996) (35)
Structure and Dynamics of Micelle-Associated Human Immunodeficiency Virus gp 41 Fusion Domain † (2009) (35)
Characterization of human and mouse granulocyte-macrophage-colony-stimulating factors derived from Escherichia coli. (1987) (35)
Folding and Purification of Insoluble (Inclusion Body) Proteins from Escherichia coli (2014) (34)
Epitope-distal effects accompany the binding of two distinct antibodies to hepatitis B virus capsids. (2013) (34)
Inhibition of HIV-1 replication by a peptide dimerization inhibitor of HIV-1 protease. (2006) (34)
Albinism-Causing Mutations in Recombinant Human Tyrosinase Alter Intrinsic Enzymatic Activity (2014) (32)
Determination of the secondary structure of the DNA binding protein Ner from phage Mu using 1H homonuclear and 15N-1H heteronuclear NMR spectroscopy. (1989) (31)
Purification and characterization of human interleukin‐1α produced in Escherichia coli (1987) (31)
Sizing up large protein complexes by electrospray ionisation-based electrophoretic mobility and native mass spectrometry: morphology selective binding of Fabs to hepatitis B virus capsids (2013) (30)
Preparation and characterization of bovine growth hormones produced in recombinant Escherichia coli. (1987) (30)
Purification and characterization of a methionine-specific aminopeptidase from Salmonella typhimurium. (1989) (30)
Purification and characterization of the DNA-binding protein Ner of bacteriophage Mu. (1988) (30)
Epitope diversity of hepatitis B virus capsids: quasi-equivalent variations in spike epitopes and binding of different antibodies to the same epitope. (2006) (30)
Biophysical Characterization of gp41 Aggregates Suggests a Model for the Molecular Mechanism of HIV-associated Neurological Damage and Dementia* (2000) (30)
P2′ Benzene Carboxylic Acid Moiety Is Associated with Decrease in Cellular Uptake: Evaluation of Novel Nonpeptidic HIV-1 Protease Inhibitors Containing P2 bis-Tetrahydrofuran Moiety (2013) (29)
Monomer-dimer equilibrium of normal and modified beta A3-crystallins: experimental determination and molecular modeling. (2000) (29)
A 1H‐NMR study of human interleukin‐1β (1986) (29)
Energetics of domain-domain interactions and entropy driven association of beta-crystallins. (2004) (29)
Native cytokines do not bind to uromodulin (Tamm‐Horsfall glycoprotein) (1988) (29)
Secondary structure of the ribonuclease H domain of the human immunodeficiency virus reverse transcriptase in solution using three-dimensional double and triple resonance heteronuclear magnetic resonance spectroscopy. (1991) (28)
Generation and characterization of a chimeric rabbit/human Fab for co-crystallization of HIV-1 Rev. (2010) (28)
Folding and Purification of Insoluble (Inclusion Body) Proteins from Escherichia coli (1995) (27)
A recombinant Chinese hamster ovary cell line containing a 300-fold amplified tetramer of the hepatitis B genome together with a double selection marker expresses high levels of viral protein. (1986) (26)
Characterization of recombinant-derived granulocyte-colony stimulating factor (G-CSF). (1988) (26)
Human Immunodeficiency Virus (HIV) gp41 Escape Mutants: Cross-Resistance to Peptide Inhibitors of HIV Fusion and Altered Receptor Activation of gp120 (2005) (25)
Nucleolar protein B23: bacterial expression, purification, oligomerization and secondary structures of two isoforms. (1993) (24)
Spectroscopic Evidence for a Common Electron Transfer Pathway for Two Tryptophan Tryptophylquinone Enzymes (*) (1995) (24)
Assessment of differences in the conformational flexibility of hepatitis B virus core‐antigen and e‐antigen by hydrogen deuterium exchange‐mass spectrometry (2014) (23)
Association properties of betaB1- and betaA3-crystallins: ability to form heterotetramers. (2008) (23)
Preparation, characterization and application of interleukin-1 beta mutant proteins with surface-accessible cysteine residues. (1989) (22)
Shared motifs of the capsid proteins of hepadnaviruses and retroviruses suggest a common evolutionary origin (1998) (22)
N-terminal extension of beta B1-crystallin: identification of a critical region that modulates protein interaction with beta A3-crystallin. (2009) (22)
Identification and localization of bound internal water in the solution structure of interleukin 1 beta by heteronuclear three-dimensional 1H rotating-frame Overhauser 15N-1H multiple quantum coherence NMR spectroscopy. (1990) (22)
Human interleukin‐5 expressed in Escherichia coli: assignment of the disulfide bridges of the purified unglycosylated protein (1991) (21)
Structural biophysics of the NusB:NusE antitermination complex. (2008) (21)
Specificity of an anti-capsid antibody associated with Hepatitis B Virus-related acute liver failure. (2013) (21)
Role of the propeptide in controlling conformation and assembly state of hepatitis B virus e-antigen. (2011) (21)
Molecular basis for the high degree of antigenic cross-reactivity between hepatitis B virus capsids (HBcAg) and dimeric capsid-related protein (HBeAg): insights into the enigmatic nature of the e-antigen. (2010) (21)
Non-canonical binding of an antibody resembling a naïve B cell receptor immunoglobulin to hepatitis B virus capsids. (2008) (21)
A proton nuclear magnetic resonance assignment and secondary structure determination of recombinant human thioredoxin. (1989) (21)
Determination of the contributions of individual aromatic residues to the CD spectrum of IL-1 beta using site directed mutagenesis. (2009) (20)
Low resolution structure of interleukin-1 beta in solution derived from 1H-15N heteronuclear three-dimensional nuclear magnetic resonance spectroscopy. (1990) (20)
Use of Protein Folding Reagents (2016) (20)
N‐terminal‐methionylated interleukin‐1β has reduced receptor‐binding affinity (1987) (19)
Is human thioredoxin monomeric or dimeric? (2008) (19)
Secondary structure and signal assignments of human-immunodeficiency-virus-1 protease complexed to a novel, structure-based inhibitor. (1994) (19)
Evidence that high mannose glycopeptides are able to functionally interact with recombinant tumor necrosis factor and recombinant interleukin 1. (1990) (19)
A Cell-penetrating Antibody Fragment against HIV-1 Rev Has High Antiviral Activity (2014) (19)
The Structure of HIV-1 Rev Filaments Suggests a Bilateral Model for Rev-RRE Assembly. (2016) (18)
Thermodynamic Analysis of Weak Protein Interactions Using Sedimentation Equilibrium (2014) (18)
The structure of the transcriptional antiterminator NusB from Escherichia coli (2000) (17)
Sequence specificity in the higher-order interaction of the Rev protein of HIV-1 with its target sequence, the RRE. (1995) (17)
Chromatofocusing of N-terminally processed forms of proteins. Isolation and characterization of two forms of interleukin-1 beta and of bovine growth hormone. (1987) (17)
Overview of the Purification of Recombinant Proteins Produced in Escherichia coli (2002) (17)
Preparation of Soluble Proteins from Escherichia coli (2005) (17)
Analysis and characterization of dimerization inhibition of a multi-drug-resistant human immunodeficiency virus type 1 protease using a novel size-exclusion chromatographic approach. (2009) (17)
HIV-1 envelope protein gp41: an NMR study of dodecyl phosphocholine embedded gp41 reveals a dynamic prefusion intermediate conformation. (2014) (17)
The TYRP1‐mediated protection of human tyrosinase activity does not involve stable interactions of tyrosinase domains (2019) (17)
Increased sensitivity of amino-arm truncated betaA3-crystallin to UV-light-induced photoaggregation. (2005) (16)
3D NMR experiments for measuring 15N relaxation data of large proteins: application to the 44 kDa ectodomain of SIV gp41. (1998) (16)
A Conserved Hydrogen-Bonding Network of P2 bis-Tetrahydrofuran-Containing HIV-1 Protease Inhibitors (PIs) with a Protease Active-Site Amino Acid Backbone Aids in Their Activity against PI-Resistant HIV (2014) (16)
The Initial Step in Human Immunodeficiency Virus Type 1 GagProPol Processing Can Be Regulated by Reversible Oxidation (2010) (14)
Beta-crystallin association. (2004) (14)
Preparation and Extraction of Insoluble (Inclusion‐Body) Proteins from Escherichia coli (1995) (13)
Beta-crystallin association. (2004) (13)
Membrane-associated human tyrosinase is an enzymatically active monomeric glycoprotein (2018) (13)
Purification of Recombinant Human Tyrosinase from Insect Larvae Infected with the Baculovirus Vector. (2017) (12)
Purification of Recombinant Proteins (2002) (12)
Structure of an RNA Aptamer that Can Inhibit HIV-1 by Blocking Rev-Cognate RNA (RRE) Binding and Rev-Rev Association. (2018) (12)
DETERMINATION OF THE RATE OF MONOMER INTERCHANGE IN A LIGAND-BOUND HOMODIMERIC PROTEIN FROM NOESY CROSS PEAKS : APPLICATION TO THE HIV PROTEASE/KNI-52 9 COMPLEX (1999) (12)
Cryo-EM study of Hepatitis B virus core antigen capsids decorated with antibodies from a human patient. (2012) (11)
Site directed mutants of human interleukin‐1α: A 1H‐NMR and receptor binding study (1988) (10)
A new HIV-1 Rev structure optimizes interaction with target RNA (RRE) for nuclear export. (2018) (10)
Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300 (2021) (10)
Purification and characterization of human interleukin-1 beta expressed in recombinant Escherichia coli. (1986) (10)
Structures of Hepatitis B Virus Core- and e-Antigen Immune Complexes Suggest Multi-point Inhibition. (2018) (10)
Protein Stability and Functional Characterization of Intra-Melanosomal Domain of Human Recombinant Tyrosinase-Related Protein 1 (2020) (8)
The structure of the transcriptional antiterminator NusB from Escherichia coli. (2000) (8)
Preparation of Soluble Proteins from Escherichia coli (1995) (8)
Structure and partial amino acid sequence of calf thymus DNA topoisomerase II: comparison with other type II enzymes. (1990) (7)
βB1-Crystallin: Thermodynamic Profiles of Molecular Interactions (2012) (7)
Expression of quasi-equivalence and capsid dimorphism in the Hepadnaviridae (2020) (7)
Expression and Purification of ZASP Subdomains and Clinically Important Isoforms: High-Affinity Binding to G-Actin. (2017) (7)
Development of a novel, pan-variant aerosol intervention for COVID-19 (2021) (6)
THE CRYSTAL STRUCTURE OF THE SIV GP41 ECTODOMAIN AT 1.47 A (1999) (6)
Conformational changes in tubulin upon binding cryptophycin-52 reveal its mechanism of action (2021) (6)
Use of Protein Folding Reagents (1995) (6)
Overview of the Characterization of Recombinant Proteins (1995) (6)
Structural characterization of the Myxococcusxanthus encapsulin and ferritin-like cargo system gives insight into its iron storage mechanism. (2022) (6)
Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizer (2022) (6)
Association properties of β B 2-and β A 3-crystallin : ability to form dimers (1998) (6)
Cloning and nucleotide sequence of the Salmonella typhimurium pepM gene (1990) (6)
HIV‐1 gp41 transmembrane oligomerization monitored by FRET and FCS (2018) (5)
Chimeric rabbit/human Fab antibodies against the hepatitis Be-antigen and their potential applications in assays, characterization, and therapy (2017) (5)
The state of the N-terminus of recombinant proteins: determination of N-terminal methionine (formylated, acetylated, or free). (1987) (5)
Pyruvic acid is attached through its central carbon atom to the amino terminus of the recombinant DNA-derived DNA-binding protein Ner of bacteriophage Mu. (1992) (5)
Purification and characterization of 5-ketofructose reductase from Erwinia citreus. (1988) (5)
Identification of Protein Interactions (2001) (4)
Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300 (2021) (4)
Purification and characterization of human interleukin-la produced in Escherichia coli (1987) (4)
NMR Experiments for Measuring 15 N Relaxation Data of Large Proteins : Application to the 44 kDa Ectodomain of SIV gp 41 (1998) (3)
Analysis of the backbone dynamics of interleukin-1 .beta. using two-dimensional inverse detected heteronuclear nitrogen-15-proton NMR spectroscopy [Erratum to document cited in CA113(9):76266p] (1991) (3)
Cross-linking of isolated oligomycin-insensitive adenosine triphosphatase from ox heart mitochondria. (1975) (3)
High-Resolution Three-Dimensional Structure of Interleukin 1 , 6 in Solution by Three-and Four-Dimensional Nuclear Magnetic Resonance Spectroscopy + (2001) (2)
Purification and characterization of human interleukin-1 alpha produced in Escherichia coli. (1987) (2)
The polypeptides of the ox heart mitochondrial inner membrane: isolation of the major component. (1975) (2)
Biochemical estimation of hepatitis B surface antigen in recombinant yeast (1987) (2)
Recombinant-derived interleukin-1 alpha stabilized against specific deamidation. (1987) (2)
Different effects of pH on the refolding of proteins (1987) (2)
Generation and use of antibody fragments for structural studies of proteins refractory to crystallization. (2014) (2)
Activation of virus uptake through induction of macropinocytosis with a novel polymerizing peptide (2014) (2)
N-terminal-methionylated interleukin-1 beta has reduced receptor-binding affinity. (1987) (2)
β-Crystallin association [Experimental Eye Research 79 (2004) 377–383] (2004) (2)
A 1H-NMR study of human interleukin-1 beta. Sequence-specific assignment of aromatic residues using site-directed mutant proteins. (1986) (2)
Site directed mutants of human interleukin-1 alpha: a 1H-NMR and receptor binding study. (1988) (2)
Human Modified Tyrosinase And Two Temperature-Sensitive Mutants Are Soluble Active Enzymes (2012) (1)
Molecular Functional Studies of HIV-1 REV and NEF Proteins (1991) (1)
IL-12p35 induces expansion of IL-10 and IL-35-expressing regulatory B cells and ameliorates autoimmune disease (2017) (1)
Characterization of Recombinant Proteins (2003) (1)
Molecular basis for the high degree of antigenic cross reactivity between hepatitis B virus capsids (HBcAg) and subunits: Insights into the enigmatic nature of e-antigen (2010) (1)
Crystal Structure of Hepatitis B Virus e-antigen (2013) (1)
Preface (2001) (1)
Capsids of hepatitis B virus e antigen with authentic C termini are stabilized by electrostatic interactions (2019) (1)
Production of Recombinant Proteins (2007) (1)
Conserved hydrogen-bonding network of P2 bis-tetrahydrofuran (2014) (1)
THE FLAME PHOTOMETRIC DETERMINATION OF LITHIUM USING INFRA-RED BARRIER LAYER CELLS (1956) (0)
Production of Recombinant Proteins (2006) (0)
Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with amprenavir (2014) (0)
Characterization of Recombinant Proteins (2003) (0)
Production of Recombinant Proteins (2009) (0)
(Recombinant DNA; phage I pL promoter; c repressor; clear-plaque phenotype; protein processing; protease- deficient Escherichiu coli B ; thermoinducible Ner-mediated immunity; prophage; lysogeny) (1988) (0)
The Homotrimeric HIV-1 Viral Coat Protein GP41 is Highly Dynamic (2013) (0)
Crystal structure of wild type HIV-1 protease in complex with non-peptidic inhibitor, GRL007 (2013) (0)
PDB/EMDB validation report for T = 3 capsid (PDB: 6UI6). (2020) (0)
Production of Recombinant Proteins (2002) (0)
Heat–Induced Aggregation and Binding to –Crystallin of Amino–Arm Truncated ßA3–Crystallin (2006) (0)
ZASP Mutations in Actin-binding Domain Cause Disruption of Skeletal Muscle Actin Filaments in Myofibrillar Myopathy (2014) (0)
Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with non-peptidic inhibitor, GRL0519 (2016) (0)
Two Forms of Hepatitis B Virus Capsid Distinguished by a Handedness-Determination Experiment (2007) (0)
Main contact page for the Protein Expression Laboratory (2007) (0)
Homo- and Hetero-Associations of βB1-Crystallin Are Dominated by Enthalpy (2010) (0)
Main staff members page for the Protein Expression Laboratory (2007) (0)
Computational alanine scanning interface analysis of T = 4 capsids1. (2020) (0)
Quantitation of Protein Interactions (2003) (0)
Single-Molecule Dynamics of a Trimeric Aspartate Transporter (2013) (0)
HIV Escape From Peptide Fusion Inhibitors (2005) (0)
Long-range lsN-lH correlation as an aid to sequential proton resonance assignment of proteins Application to the DNA-binding protein ner from phage (2001) (0)
The N-Terminal Extensions in Homo- and Hetero-Associations of β-Crystallins (2009) (0)
SOLUTION STRUCTURE OF ESCHERICHIA COLI NUSB (2000) (0)
Preparation and characterization of bovine growth hormones (2005) (0)
Hepatitis B core-antigen in complex with Fab e21 (2018) (0)
Identification of Protein Interactions (2004) (0)
Comparison of the quality of structures in this study with reference structures. (2020) (0)
Innentitelbild: Stability and Shape of Hepatitis B Virus Capsids In Vacuo (Angew. Chem. 33/2008) (2008) (0)
Identification of Protein Interactions (2006) (0)
Preface (2005) (0)
Conformational analysis of chain pairs with Dyndom1. (2020) (0)
Hepatitis B e-antigen in complex with scFv e13 (2018) (0)
Inside Cover: Stability and Shape of Hepatitis B Virus Capsids In Vacuo (Angew. Chem. Int. Ed. 33/2008) (2008) (0)
Identification of Protein Interactions (2005) (0)
PURIFICATION OF A PROTEIN EXPRESSED IN ESCHERICHIA COLI IN A SOLUBLE STATE : INTERLEUKIN 1 β Materials (2005) (0)
Vive La Différence! Mapping Macromolecular Complexes by Generalized Difference Imaging (2000) (0)
Quantitation of Protein Interactions (2005) (0)
Preface (2012) (0)
HIV-1 NEF (REGULATORY FACTOR), NMR, 40 STRUCTURES (1996) (0)
X-ray crystal structure of wild type HIV-1 protease in complex with GRL-09510 (2017) (0)
IL-12p35 single chain subunit antagonizes IL-6 mediated STAT1 and STAT3 activation and prevents expansion of Th17 cells in experimental autoimmune uveitis (CCR1P.246) (2014) (0)
Crystal structure of wild type HIV-1 protease in complex with non-peptidic inhibitor, GRL008 (2013) (0)
HBV T=4 149C3A (2019) (0)
All-atom RMSD (Å) of chain-pairs in select core-antigen structures1. (2020) (0)
Quantitation of Protein Interactions (2005) (0)
Identification of Protein Interactions (2007) (0)
HIV-1 Rev assembly domain (residues 1-69) (2018) (0)
Filaments in Myofibrillar Myopathy Cause Disruption of Skeletal Muscle Actin Mutations in the Actin-binding Domain PDZ Motif-containing Protein ( ZASP ) Z-disc-associated , Alternatively Spliced , Molecular Bases of Disease : (2014) (0)
Structure, Dynamics and Interactions of Hiv-1 Protease-Inhibitor Complexes (1995) (0)
Oculocutaneous albinism Type 1 mutations indicate changes in the recombinant tyrosinase folding and activity. (2015) (0)
Commentary on the article: Purification and characterization of the Ner repressor of bacteriophage Mu (1989) FEBS Lett. 244, 369–375 G. Kukolj, P.P. Tolias and M.S. DuBow (1989) (0)
PDB/EMDB validation report for T = 4 capsid (PDB: 6UI7). (2020) (0)
Crystal structure of wild type HIV-1 protease in complex with darunavir (2013) (0)
HIV-1 PROTEASE-DMP323 COMPLEX IN SOLUTION, NMR MINIMIZED AVERAGE STRUCTURE (1996) (0)
Structure of the T=3 Hepatitis B Virus Capsid at 3.6Å Resolution (2013) (0)
Solution NMR Studies of the HIV-1 Protease/Inhibitor Complex : The HIV-1 Protease Catalytic Aspartyl Side-Chain Carboxyl Groups Have Distinct Protonation States in the Complex Formed with the Asymmetric Inhibitor KNI-272 (1996) (0)
The consequences of deglycosylation of intra-melanosomal domain of human tyrosinase. (2014) (0)
Crystal Structure of an anti-HBV e-antigen monoclonal Fab fragment (e6), unbound (2013) (0)
HAIRPIN LOOP CONTAINING DOMAIN OF HEPATOCYTE GROWTH FACTOR, NMR, MINIMIZED AVERAGE STRUCTURE (1998) (0)
Identification of Protein Interactions (2001) (0)
Solution structure of NusB from Aquifex Aeolicus (2008) (0)
HIV-1 PROTEASE-DMP323 COMPLEX IN SOLUTION, NMR, 28 STRUCTURES (1996) (0)
HIV-1 Rev NTD dimers with variable crossing angles (2016) (0)
Specific ComplexofHumanImmunodeficiency VirusType1Rev andNucleolar B23Proteins: Dissociation bytheRev Response Element (1991) (0)
Purification of Recombinant Proteins (2002) (0)
THE PARATOPE Activity : CHARACTERIZATION OF against HIV-1 Rev Has High Antiviral A Cell-penetrating Antibody Fragment Protein Structure and Folding : (2014) (0)
Preparation of Soluble Proteins from Escherichia coli (1995) (0)
HBV core-antigen related structures in the EMDB and PDB databases1. (2020) (0)
Antigenic Diversity of the Hepatitis B Virus Capsid (2005) (0)
STING-SAVI nejm appendix (2015) (0)
PISA intra-dimer interface analysis of T = 3 and T = 4 capsids. (2020) (0)
The Tyrp1 protection of human tyrosinase activity do not involve interaction between tyrosinase domains. (2018) (0)
Identification of Protein Interactions (2006) (0)
Identification of Protein Interactions (2012) (0)
Main publications page for the Protein Expression Laboratory (2007) (0)
Crystal structure of wild type HIV-1 protease in complex with GRL-10413 (2016) (0)
HBV T=3 149C3A (2019) (0)
Nucleic Acid Content of HBV Capsids Depends on its CTD-Phosphorylation State (2013) (0)
Purification and Characterization of Recombinant Human Tyrosinase Related Protein 1 (2017) (0)
Quantitation of Protein Interactions (2006) (0)
Protein Expression Laboratory Main Page (2001) (0)
STING-SAVI Paper NEJM (2015) (0)
Crystal structure of HIV-1 Rev (residues 1-93)-RNA aptamer complex (2018) (0)
A Proton Nuclear Magnetic Resonance Assignment and Secondary Structure Determination of Recombinant Human Thioredoxint (2001) (0)
Computational alanine scanning interface analysis of T = 3 capsids1. (2020) (0)
Enzymology of Succinate:Ubiquinone Reductase in Detergent Solution and Reconstituted Membranes (1981) (0)
Solution structure of micelle-bound fusion domain of HIV-1 gp41 (2005) (0)
Purification and characterization of the reverse transcriptase expressed in recombinant September 1990 RNase H domain of HIV-l Escherichia coli (2001) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Paul T. Wingfield?

Paul T. Wingfield is affiliated with the following schools:

Paul T. Wingfield's Academic­Influence.com Rankings

Paul T. Wingfield's Degrees

Similar Degrees You Can Earn

Why Is Paul T. Wingfield Influential?

Paul T. Wingfield's Published Works

Published Works

What Schools Are Affiliated With Paul T. Wingfield?

Paul T. Wingfield's AcademicInfluence.com Rankings